Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

V617FJAK2-Positive Endothelial Cells Are Present in Bone Marrow Neovessels of Patients with Myelofibrosis and Could Derive from the Transdifferentiation of Mutated Hematopoietic Cells

Laura Villani, BS,, Rita Campanelli, BS, Gabriella Gaudioso, BS, Valentina Poletto, PhD, Elisa Bonetti, PhD, Paolo Catarsi, BS, Gabriela Fois, BS, Benedetta G Erba, PhD, Margherita Massa, PhD, Umberto Magrini, MD, Giovanni Barosi, MD, Umberto Gianelli, MD, Vittorio Rosti, MD

Blood (2015) 126 (23): 2833.

https://doi.org/10.1182/blood.V126.23.2833.2833

Published: 2015

Journal Articles

Reduced Frequency of CD4+CD25++CD127low/-FOXP3+ Regulatory T Cells in Patients with Primary Myelofibrosis

Margherita Massa, PhD, Rita Campanelli, BS, Gabriela Fois, BS, Laura Villani, BS,, Elisa Bonetti, PhD, Paolo Catarsi, BS, Valentina Poletto, PhD, Gianluca Viarengo, MD, Vittorio Rosti, MD, Giovanni Barosi, MD

Blood (2015) 126 (23): 2809.

https://doi.org/10.1182/blood.V126.23.2809.2809

Published: 2015

Journal Articles

Possible Role of Impaired Erk1,2 Phosphorilation and Increased sIL2r Alpha Plasma Levels in the Reduced Frequency of Circulating T Regulatory Cells of Patients with Primary Myelofibrosis

Rita Campanelli, BS, Gabriela Fois, BS, Carlotta Abbà, BS, Mara De Amici, BS, Laura Villani, BS,, Elisa Bonetti, PhD, Paolo Catarsi, BS, Valentina Poletto, PhD, Giovanni Barosi, MD, Vittorio Rosti, MD, Margherita Massa, PhD

Blood (2015) 126 (23): 1639.

https://doi.org/10.1182/blood.V126.23.1639.1639

Published: 2015

Journal Articles

Long Term Follow up of a Phase 2 Study of Ruxolitinib in Patients with Splanchnic Vein Thrombosis Associated with Myeloproliferative Neoplasm

Blood (2015) 126 (23): 2803.

https://doi.org/10.1182/blood.V126.23.2803.2803

Published: 2015

Journal Articles

What Is the True Response Rate to Ruxolitinib in Persons with Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis (MF) Needing Therapy for Splenomegaly ?

Giovanni Barosi, MD, Valentina Poletto, Biol Sci, Elisa Bonetti, BS, Laura Villani, Biol Sci, Paolo Catarsi, PhD, Gianluca Viarengo, MD, Rita Campanelli, Biol. Sci, Margherita Massa, PhD, Vittorio Rosti, MD

Blood (2014) 124 (21): 3191.

https://doi.org/10.1182/blood.V124.21.3191.3191

Published: 2014

Journal Articles

Phenotypical, Functional and Genetic Characterization of Mesenchymal Stem Cells Derived from the Spleen of Patients with Myelofibrosis

Blood (2014) 124 (21): 3227.

https://doi.org/10.1182/blood.V124.21.3227.3227

Published: 2014

Journal Articles

Decrease Of T Regulatory Cells In Patients With Myelofibrosis Receiving Ruxolitinib

Giovanni Barosi, MD, Rita Campanelli, Biol. Sci, Gabriela Fois, Biol. Sci, Valentina Poletto, Biol. Sci, Laura Villani, Biol. Sci, Elisa Bonetti, BS, Paolo Catarsi, PhD, Vittorio Rosti, MD, Margherita Massa, PhD

Blood (2013) 122 (21): 4057.

https://doi.org/10.1182/blood.V122.21.4057.4057

Published: 2013

Journal Articles

Somatic and Germ-Line Molecular Characteristics Of Prefibrotic Myelofibrosis

Giovanni Barosi, MD, Elisa Bonetti, BS, Paolo Catarsi, PhD, Margherita Massa, PhD, Rita Campanelli, Biol.Sci, Valentina Poletto, Biol.Sci, Gianluca Viarengo, MD, Laura Villani, Biol.Sci, Gabriela Fois, Biol.Sci, Flavia Biamonte, BiSci, PhD, Giada Rotunno, BiSci, Paola Guglielmelli, PhD MD, Umberto Magrini, MD, Alessandro M Vannucchi, MD, Vittorio Rosti, MD

Blood (2013) 122 (21): 4058.

https://doi.org/10.1182/blood.V122.21.4058.4058

Published: 2013

Journal Articles

High Frequency of Circulating Endothelial Colony Forming Cells (ECFCs) in Myeloproliferative Neoplasms (MPNs) Is Associated with Diagnosis of Prefibrotic Myelofibrosis, History of Splanchnic Vein Thrombosis, and Vascular Splenomegaly.

Vittorio Rosti, MD, Elisa Bonetti, Gaetano Bergamaschi, MD, Rita Campanelli, PhD, Elisabetta Gattoni, MD, Sonia Lo Po, Umberto Magrini, MD, Margherita Massa, PhD, Alessandro Vannucchi, MD, Gianluca Viarengo, MD, Paola Guglielmelli, MD, Massimo Primignani, MD, Giovanni Barosi, MD

Blood (2009) 114 (22): 309.

https://doi.org/10.1182/blood.V114.22.309.309

Published: 2009

Journal Articles

Kinetics of CD34+ Cells in the Peripheral Blood of Patients with Primary Myelofibrosis Undergoing Splenectomy

Rita Campanelli, PhD, Margherita Massa, PhD, Elisa Bonetti, Gianluca Viarengo, MD, Vittorio Rosti, MD, Elisabetta Gattoni, MD, Enza Moretti, Gaetano Bergamaschi, MD, Laura Villani, PhD, Marco Lucioni, MD, Laura Bandiera, MD, Roberta Riboni, PhD, Gianni Barosi, MD

Blood (2008) 112 (11): 3725.

https://doi.org/10.1182/blood.V112.11.3725.3725

Published: 2008

Journal Articles

Circulating Endothelial Progenitor Cells Are Increased in Patients with Myelofibrosis and Do Not Harbor V617F JAK-2 or W515L MPL Mutations

Elisa Bonetti, Vittorio Rosti, MD, Laura Villani, PhD, Rita Campanelli, PhD, Gaetano Bergamaschi, MD, Margherita Massa, PhD, Alessandro Pecci, MD, Alessandro M. Vannucchi, MD, Francesco Frassoni, MD, Giovanni Barosi, MD

Blood (2007) 110 (11): 1535.

https://doi.org/10.1182/blood.V110.11.1535.1535

Published: 2007

Journal Articles

Reduced CD26 Dipeptidylpeptidase IV Membrane Expression and Activity of CD34+ Cells from Patients with Myelofibrosis with Myeloid Metaplasia.

Rita Campanelli, Margherita Massa, PhD, Vittorio Rosti, MD, Gaetano Bergamaschi, MD, Gianluca Viarengo, MD, Monia Marchetti, MD, Ronald Hoffman, MD, Giovanni Barosi, MD

Blood (2006) 108 (11): 3617.

https://doi.org/10.1182/blood.V108.11.3617.3617

Published: 2006

Journal Articles

Reconstitution of Endothelial Progenitor Cells after Allogeneic Bone Marrow Transplantation in Children with Malignancies.

Vittorio Rosti, MD, Margherita Massa, PhD, Elisa Bonetti, PhD, Rita Campanelli, PhD, Valentina Meli, PhD, Claudia Castelnovi, MD, Daniela Lisini, PhD, Daria Pagliara, MD, Tommaso Mina, MD, Maria E. Bernardo, MD, Daniela Montagna, PhD, Rita Maccario, PhD, Franco Locatelli, MD

Blood (2005) 106 (11): 3026.

https://doi.org/10.1182/blood.V106.11.3026.3026

Published: 2005

Journal Articles

Reduced Expression of CXCR4 on Circulating CD34+ Cells Is Associated with Hematopoietic Progenitor Cells (HPC) Mobilization in Patients with Myelofibrosis with Myeloid Metaplasia (MMM).

Margherita Massa, PhD, Vittorio Rosti, MD, Alessandro M. Vannuccchi, MD, Rita Campanelli, BSci, Alessandro Pecci, MD, Gianluca Viarengo, MD, Valentina Meli, MD, Monia Marchetti, MD, Paola Guglielmelli, MD, Edward Bruno, MD, Ming Xu, MD, Ronald Hoffman, PhD, Giovanni Barosi, MD

Blood (2005) 106 (11): 258.

https://doi.org/10.1182/blood.V106.11.258.258

Published: 2005

Journal Articles

Incidence and Clinical Profile of JAK2 V617F Mutation in Myelofibrosis with Myeloid Metaplasia.

Giovanni Barosi, MD, Monia Marchetti, MD, Margherita Massa, PhD, Vittorio Rosti, MD, Alessandro Vannucchi, MD, Rosangela Invernizzi, MD, Rita Campanelli, BSc, Gianluca Viarengo, MD, Umberto Magrini, PhD, Gaetano Bergamaschi, MD

Blood (2005) 106 (11): 256.

https://doi.org/10.1182/blood.V106.11.256.256

Published: 2005

Journal Articles

Clonal Origin of Circulating Endothelial Progenitor Cells in Patients with Myelofibrosis with Myeloid Metaplasia.

Gaetano Bergamaschi, MD, Tiziano Pramparo, PhD, Vittorio Rosti, MD, Isabella Ramajoli, PhD, Giuliana Gregato, PhD, Margherita Massa, PhD, Monia Marchetti, MD, Orsetta Zuffardi, PhD, Mario Cazzola, MD, Giovanni Barosi, MD

Blood (2004) 104 (11): 2427.

https://doi.org/10.1182/blood.V104.11.2427.2427

Published: 2004

Journal Articles

Evaluation of Cytokines Mobilizing Hematopoietic Progenitor Cells in Patients with Myelofibrosis with Myeloid Metaplasia (MMM).

Rita Campanelli, PhD, Margherita Massa, PhD, Valentina Meli, Vittorio Rosti, MD, Isabella Ramajoli, PhD, Alessandro Pecci, MD, Gian Luca Viarengo, MD, Monia Marchetti, MD

Blood (2004) 104 (11): 2434.

https://doi.org/10.1182/blood.V104.11.2434.2434

Published: 2004

NARROW

V617FJAK2-Positive Endothelial Cells Are Present in Bone Marrow Neovessels of Patients with Myelofibrosis and Could Derive from the Transdifferentiation of Mutated Hematopoietic Cells

Reduced Frequency of CD4+CD25++CD127low/-FOXP3+ Regulatory T Cells in Patients with Primary Myelofibrosis

Possible Role of Impaired Erk1,2 Phosphorilation and Increased sIL2r Alpha Plasma Levels in the Reduced Frequency of Circulating T Regulatory Cells of Patients with Primary Myelofibrosis

Long Term Follow up of a Phase 2 Study of Ruxolitinib in Patients with Splanchnic Vein Thrombosis Associated with Myeloproliferative Neoplasm

What Is the True Response Rate to Ruxolitinib in Persons with Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis (MF) Needing Therapy for Splenomegaly ?

Phenotypical, Functional and Genetic Characterization of Mesenchymal Stem Cells Derived from the Spleen of Patients with Myelofibrosis

Decrease Of T Regulatory Cells In Patients With Myelofibrosis Receiving Ruxolitinib

Somatic and Germ-Line Molecular Characteristics Of Prefibrotic Myelofibrosis

High Frequency of Circulating Endothelial Colony Forming Cells (ECFCs) in Myeloproliferative Neoplasms (MPNs) Is Associated with Diagnosis of Prefibrotic Myelofibrosis, History of Splanchnic Vein Thrombosis, and Vascular Splenomegaly.

Kinetics of CD34+ Cells in the Peripheral Blood of Patients with Primary Myelofibrosis Undergoing Splenectomy

Circulating Endothelial Progenitor Cells Are Increased in Patients with Myelofibrosis and Do Not Harbor V617F JAK-2 or W515L MPL Mutations

Reduced CD26 Dipeptidylpeptidase IV Membrane Expression and Activity of CD34+ Cells from Patients with Myelofibrosis with Myeloid Metaplasia.

Reconstitution of Endothelial Progenitor Cells after Allogeneic Bone Marrow Transplantation in Children with Malignancies.

Reduced Expression of CXCR4 on Circulating CD34+ Cells Is Associated with Hematopoietic Progenitor Cells (HPC) Mobilization in Patients with Myelofibrosis with Myeloid Metaplasia (MMM).

Incidence and Clinical Profile of JAK2 V617F Mutation in Myelofibrosis with Myeloid Metaplasia.

Clonal Origin of Circulating Endothelial Progenitor Cells in Patients with Myelofibrosis with Myeloid Metaplasia.

Evaluation of Cytokines Mobilizing Hematopoietic Progenitor Cells in Patients with Myelofibrosis with Myeloid Metaplasia (MMM).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only